Picture of Cellebrite DI logo

CLBT — Cellebrite DI News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid CapHigh Flyer

Cellebrite DI Ltd expected to post earnings of 5 cents a share - Earnings Preview

* Cellebrite DI Ltd  CLBT.OQ   CLBT.O  is expected to show a
rise
in quarterly revenue when it reports  results on August 15 for
the period ending June 30 2024
    * The Petah Tikva Israel-based   company is expected to
report a
19.6% increase in revenue to $91.713 million from $76.68 million
a year ago, according to the mean estimate from 8 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Cellebrite DI Ltd is for
earnings of 5 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cellebrite
DI Ltd
is $14.50​, above​ its last closing price of $13.34. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  0.05        0.06       0.08      Beat    42.9
 Dec. 31 2024  0.05        0.06       0.11      Beat    89.7
 Sep. 30 2023  0.05        0.05       0.10      Beat    118.9​
 Jun. 30 2023  0.02        0.02       0.05      Beat    114.3
 ​​Mar.        0.02        0.02       0.04      Beat    77.8
 31 2023                                                
 Dec. 31 2022  0.03        0.04       0.08      Beat    100​
 Sep. 30 2022  0.02        0.02       0.01      Missed  -55.6
 Jan. 1 0001   0.02        0.03       0.00      Missed  -100
 This summary was machine generated August 13 at 13:54 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Cellebrite DI

See all news